Dihydromyricetin, a multi-perspective medicinal entity
Paper Details
Dihydromyricetin, a multi-perspective medicinal entity
Abstract
Dihydromyricetin called flavonoid also known as ampelopsin and extract from Ampelopsis grossedentata, it found in various species of plants such as Japanese Raisin Tree, the Himalayan Cedar Tree, the African Blackwood but it mostly obtained from Ampelopsis grossedentata which mostly occurs in the warm climate of china. Dihydromyricetin exhibit a lot of biological activities with minimum side effects,it shows anti-cancer, apoptotic, anti-inflammatory and anti-oxidant activity, dihydromyricetin play an important role in anti-inflammation after binding to a novel binding site IKK-Cys46,it may stroll the reactive oxygen species and shows oxidative stress mediating activity and also selectively diminish cancer cell without effecting normal cells by this way it have anti-tumour activity. DHM cause the induction of apoptosis by interfering with many signaling pathways such as ERK1/2 and p38 MAPK, Bcl2/Bax, DR4 and DR5, increase activity of alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH)can cause the elimination of EtOH and by this way DHM amend the liver injuries due to alcohol consumption and so act as a novel anti-alcohol agent. Previous researches makes a lot advances in clinical applications of DHM but this is not enough further researches also need to do. Lower and hight levels of dihydromyricetin may limits its potential applications, in this review we will discuss the different biological activities of dihydromyricetin and how it works as a multi-perspective medicinal Entity.
Bonadonna G. Monfardini S. de Lena M. Fossati-Bellani F. 1969. Clinical evaluation of adriamycin, a new antitumour antibiotic. British Medical Journal 3, 503-506. https://doi.org/10.1136/bmj.3.5669.503
Chakrabarti J, Chatterjee A, Mitra A,Chattopadhyay N. 2003. Membrane-associated MMP-2 in human cervical cancer. Journal of environmental pathology, toxicology and oncology 22, 2.
Chen S, Zhao X, Wan J, Ran L. Qin Y, Wang X. Zhang Q. 2015. Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial. Pharmacological research 99, 74-81.
Chen YQ, Ni DJ, Cheng Q, Huang HB, Meng Y, WU MC. 2007. Study on the hypolipidemic effect of flavones and dihydromyricetin From Tengcha. Journal of tea science 3, 010.
Chen S, Zha X, Wan J, Ran L, Qin Y, Wang X, Zhang Q. 2015. Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial. Pharmacological research, 99, 74-81.
Heilig M, Egli M, Crabbe JC, Becker HC. 2010. Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked. Addiction biology 15, 169-184.
Hase K, Ohsugi M, Xiong Q, Basnet P, Kadota S, Namba T. 1997. Hepatoprotective Effect of Hovenia dulcis THUNB on Experimental Liver Injuries Induced by Carbon Tetrachloride or D-Galactosamine: Lipopolysaccharide. Biological and pharmaceutical Bulletin, 20, 381-385. https://doi.org/10.1248/bpb.20.381.
Hou XL, Tong Q, Wang WQ, Shi CY, Xiong W. Chen J, Fang JG. 2015. Suppression of inflammatory responses by dihydromyricetin, a flavonoid from Ampelopsis grossedentata, via inhibiting the activation of NF-κB and MAPK signaling pathways. Journal of natural products 78, 1689-1696.
Kou X, Chen N. 2012. Pharmacological potential of ampelopsin in Rattan tea. Food Science and Human Wellness 1, 14-18. https://doi.org/10.1016/j.fshw.2012.08.001
Kao SJ, Lee WJ, Chang JH, Chow JM, Chung CL, Hung WY, Chien MH. 2017. Suppression of reactive oxygen species‐mediated ERK and JNK activation sensitizes dihydromyricetin‐induced mitochondrial apoptosis in human non‐small cell lung cancer. Environmental toxicology 32, 1426-1438.
Liu DY, Zheng HQ, Luo GQ. 2003. Effects of ampelopsin on invasion and metastasis of B16 mouse melanoma in vivo and in vitro. China journal of Chinese materia medica 28, 957-961.
Liang J, Shen Y, Shao XM, Scott MB, Ly E, Wong S, Spigelman I. 2014. Dihydromyricetin prevents fetal alcohol exposure-induced behavioral and physiological deficits: the roles of GABA A receptors in adolescence. Neurochemical research 39, 1147-1161.
Le L, Jiang B, Wan W, Zhai W, Xu L, Hu K, Xiao P. 2016. Metabolomics reveals the protective of dihydromyricetin on glucose homeostasis by enhancing insulin sensitivity. Scientific reports 6, 36184.
Liang J, Lindemeyer AK, Shen Y, López-Valdés HE, Martínez-Coria H, Shao XM, Olsen RW. 2014. Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer’s disease. Neurochemical research 39, 1171-1181. https://doi.org/10.1007/s11064-014-1304-4
Le L. Jiang B, Wan W, Zhai W, Xu L, Hu K, Xiao P. 2016. Metabolomics reveals the protective of Dihydromyricetin on glucose homeostasis by enhancing insulin sensitivity. Scientific reports 6,36184.
Liang J, Lindemeyer AK, Shen Y, López-Valdés HE, Martínez-Coria H, Shao XM, Olsen RW. 2014. Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer’s disease. Neurochemical research 39, 1171-1181. http://dx.doi.org/10.1007/s11064-014-1358-3
Li X, Liu J, Lin J, Wang T, Huang J, Lin Y, Chen D. 2016. Protective effects of dihydromyricetin against• OH-induced mesenchymal stem cells damage and mechanistic chemistry. Molecules 21, 604. https://doi.org/10.3390/molecules21050604
Murakami T, Miyakoshi M, Araho D, Mizutani K, Kambara T, Ikeda T, Igarashi K. 2004. Hepatoprotective activity of tocha, the stems and leaves of Ampelopsis grossedentata, and ampelopsin. Biofactors, 21, 175-178. https://doi.org/10.3390/molecules21050604
Minko T, Dharap SS, Pakunlu RI, Wang Y. 2004. Molecular targeting of drug delivery systems to cancer. Current Drug Targets 5, 389-406.
Mulcahy RT, Wartman MA, Bailey HH, Gipp JJ. 1997. Constitutive and β-naphthoflavone-induced expression of the human γ-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. Journal of Biological Chemistry 272, 7445-7454.
Nuernberg GL. Aguiar B, Bristot G, Fleck MP, Rocha NS. 2016. Brain-derived neurotrophic factor increase during treatment in severe mental illness inpatients. Translational psychiatry 6, 985.
Primiano T, Sutter TR, Kensler TW. 1996. Antioxidant-inducible genes. In Advances in pharmacology 38, 293-32. https://doi.org/10.1016/S1054-3589(08)60989-8
Ren ZX, Zhao YF, Cao T, Zhen XC. 2016. Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson’s disease by suppressing glycogen synthase kinase-3 beta activity. Acta Pharmacologica Sinica 37, 1315.
Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. 1996. Mechanism of free fatty acid-induced insulin resistance in humans. The Journal of clinical investigation 97, 2859-2865.
Ren ZX, Zhao YF, Cao T, Zhen XC. 2016. Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson’s disease by suppressing glycogen synthase kinase-3 beta activity. Acta Pharmacologica Sinica 37, 1315.
Swain SM, Whaley FS, Ewer MS. 2003. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer: Interdisciplinary International Journal of the American Cancer Society 97, 2869-2879. https://doi.org/10.1002/cncr.11407
Suda T, Takahashi T, Golstein P, Nagata S. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell, 75, 1169-1178.
Shen Y, Lindemeyer AK, Gonzalez C, Shao XM, Spigelman I, Olsen RW, Liang J. 2012. Dihydromyricetin as a novel anti-alcohol intoxication medication. Journal of Neuroscience 32, 390-401. https://doi.org/10.1523/JNEUROSCI.4639-11.2012
Thornberry NA, Lazebnik Y. 1998. Caspases: enemies within. Science, 281, 1312-1316.
Vergely C, Delemasure S, Cottin Y, Rochette L. 2007. Preventing the cardiotoxic effects of anthracyclines: from basic concepts to clinical data. Heart Metab, 35, 1-7.
Waltner-Law ME, Wang XL, Law BK, Hall RK. Nawano M, Granner DK. 2002. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. Journal of Biological Chemistry.
Weili XHHGY, Yousheng Z. 2004. Study on the Antimicrobial Effect of the Extracts of Ampelopsis Grossedentata. Journal of Chinese Institute of Food Science and Technology 1, 016.
Wu B, Lin J, Luo J, Han D, Fan M, Guo T, Yi F. 2017. Dihydromyricetin protects against diabetic cardiomyopathy in streptozotocin-induced diabetic mice. BioMed research international, 2017. https://doi.org/10.1155/2017/3764370
Wolf BB, Green DR. 1999. Suicidal tendencies: apoptotic cell death by caspase family proteinases. Journal of Biological Chemistry 274, 20049-20052.
Wu S, Liu B, Zhang Q, Liu J, Zhou W, Wang C, Zhu R. 2013. Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells. PloS one, 8, e76886. https://doi.org/10.1371/journal.pone.0076886
Watson AJ. 2006. An overview of apoptosis and the prevention of colorectal cancer. Critical reviews in oncology/hematology 57, 107-121.
Xu B, Huang S, Wang C, Zhang H, Fang S, Zhang Y. 2017. Anti‑inflammatory effects of dihydromyricetin in a mouse model of asthma. Molecular medicine reports 15, 3674-3680. https://doi.org/10.3892/mmr.2017.6428
Zhou DZ, Sun HY, Yue JQ, Peng Y, Chen YM, Zhong ZJ. 2017. Dihydromyricetin induces apoptosis and cytoprotective autophagy through ROS-NF-κB signalling in human melanoma cells. Free radical research 51, 517-528. https://doi.org/10.1080/10715762.2017.1328552
Zhou FZ, Huang M, Zhang XY, Wu XY, Guo Y. 2012. Synergy and attenuation of dihydromyricetin on chemotherapy of transplanted S180 mice. Chinese Journal of Hospital Pharmacy 2, 008.
Zhang YS, Ning ZX, Yang SZ, Wu H. 2003. Antioxidation properties and mechanism of action of dihydromyricetin from Ampelopsis grossedentata. Acta pharmaceutica Sinica, 38, 241-244.
Zhang ZJ, Zhang XY, Li GL, YING DZ, Guo Y. 2007. Protective effect of dihydromyricetin in oxidative damage on erythrocytes and related materials. Journal of naturalscience Hunan Norma University 30, 99. https://doi.org/10.1371/journal.pone.0108314
Zhang Q, Liu J, Liu B, Xia J, Chen N, Chen X, Zhu R. 2014. Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism. Scientific reports 4, 4628. https://doi.org/10.1038/srep04628
Zhou X, Zhou T, Tan C. 1997. Effects of dihyromyricetin on contaction of rabbit aortic smooth muscle. Journal of Modern Applied Pharmacy 14, 8-11.
Zeng S, Luo GQ, Liu DY. 2006. The chemotaxis effect of ampelopsin on the immunocytes. Journal of Chinese medicinal materials 29, 260-262.
Zhao Y, Wang P, Chen S, Han C, Yan Q, Zheng L, Zhen X. 2017. Dihydromyricetin protects against cerebral ischemia/reperfusion injury via suppressing microglia-mediated neuroinflammation and activation of ERK1/2-CREB signaling pathway. Journal of Functional Foods 33, 76-84. https://doi.org/10.1016/j.jff.2017.03.034
Wencong Liu, Sadia Khatoon, Yinan Zheng, Xin-xin She, Ming-tong Gao, Zahid hussain shah, Xinglong Liu, Lulu Zeng, XueyanChen, Chuan-bo Ding (2019), Dihydromyricetin, a multi-perspective medicinal entity; IJB, V14, N5, May, P378-388
https://innspub.net/dihydromyricetin-a-multi-perspective-medicinal-entity/
Copyright © 2019
By Authors and International
Network for Natural Sciences
(INNSPUB) https://innspub.net
This article is published under the terms of the
Creative Commons Attribution License 4.0